Matrix Therapy with RGTA OTR4120 Improves Healing Time and Quality in Hairless Rats with Deep Second-Degree Burns
G. Zakine(Assistance Publique – Hôpitaux de Paris), Denis Barritault(Délégation Paris 7), J Luboinski(Centre National de la Recherche Scientifique), Dulce Papy-García(Université Paris-Est Créteil), Juan Carlos Chachques(Centre National de la Recherche Scientifique), Alain Carpentier(Hôpital Saint-Louis), Stéphanie Garcia-Filipe(Laboratoire de Recherche sur la Croissance Cellulaire, la Réparation et la Régénération Tissulaires), Véronique Barbier(Centre National de la Recherche Scientifique)
Cited by 20
Related Papers
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
|Journal of Clinical Oncology|2009|573
Continuous growth of mean tumor diameter in a subset of grade II gliomas
|Annals of Neurology|2003|485
Mitral valve disease—morphology and mechanisms
|Nature Reviews Cardiology|2015|387
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
|Journal of Biological Chemistry|2005|175